CoChat

DNA Methylation Profiling Identifies Global Methylation Differences and Markers of Adrenocortical Tumors

Open access
Rechache, Nesrin S., Wang, Yonghong, Stevenson, Holly S., Killian, J. Keith, Edelman, Daniel C., Merino, Maria, Zhang, Lisa, Nilubol, Naris, Stratakis, Constantine A., Meltzer, Paul S., Kebebew, Electron · 2012 · The Journal of Clinical Endocrinology & Metabolism
Cited by 123

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

CONTEXT: It is not known whether there are any DNA methylation alterations in adrenocortical tumors. OBJECTIVE: The objective of the study was to determine the methylation profile of normal adrenal cortex and benign and malignant adrenocortical tumors. METHODS: Genome-wide methylation status of CpG regions were determined in normal (n = 19), benign (n = 48), primary malignant (n = 8), and metastatic malignant (n = 12) adrenocortical tissue samples. An integrated analysis of genome-wide methylation and mRNA expression in benign vs. malignant adrenocortical tissue samples was also performed. RESULTS: Methylation profiling revealed the following: 1) that methylation patterns were distinctly different and could distinguish normal, benign, primary malignant, and metastatic tissue samples; 2) that malignant samples have global hypomethylation; and 3) that the methylation of CpG regions are different in benign adrenocortical tumors by functional status. Normal compared with benign samples had the least amount of methylation differences, whereas normal compared with primary and metastatic adrenocortical carcinoma samples had the greatest variability in methylation (adjusted P ≤ 0.01). Of 215 down-regulated genes (≥2-fold, adjusted P ≤ 0.05) in malignant primary adrenocortical tumor samples, 52 of these genes were also hypermethylated. CONCLUSIONS: Malignant adrenocortical tumors are globally hypomethylated as compared with normal and benign tumors. Methylation profile differences may accurately distinguish between primary benign and malignant adrenocortical tumors. Several differentially methylated sites are associated with genes known to be dysregulated in malignant adrenocortical tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2011-3298

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 123

Metadata

Authors
Rechache, N. S., Wang, Y., Stevenson, H. S., Killian, J. K., Edelman, D. C., Merino, M., Zhang, L., Nilubol, N., Stratakis, C. A., Meltzer, P. S., & Kebebew, E.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2012-06-01
Volume
97
Issue
6
Pages
E1004-E1013
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2032999587
Cited by
123
References
11
FWCI
10.52
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DNA Methylation Profiling Identifies Global Methylation Differences and Markers of Adrenocortical Tumors. https://app.cochat.ai/papers/10.1210/jc.2011-3298
The paper
Rechache, N. S., Wang, Y., Stevenson, H. S., Killian, J. K., Edelman, D. C., Merino, M., Zhang, L., Nilubol, N., Stratakis, C. A., Meltzer, P. S., & Kebebew, E. (2012). DNA Methylation Profiling Identifies Global Methylation Differences and Markers of Adrenocortical Tumors. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2011-3298

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.